ACN
54
-2
DLTR
58
-5
KSS
58
-4
CAG
34
-2
TGT
50
-7
PPL
57
2
MHK
45
2
PH
64
2
OI
58
11
AMGN
38
4
SRE
47
2
ICE
60
3
GE
77
5
MDLZ
26
-2
PFE
45
12
AME
75
3
NKE
31
-5
SLG
37
6
LB
33
2
AXP
74
4
ACN
54
-2
DLTR
58
-5
KSS
58
-4
CAG
34
-2
TGT
50
-7
PPL
57
2
MHK
45
2
PH
64
2
OI
58
11
AMGN
38
4
SRE
47
2
ICE
60
3
GE
77
5
MDLZ
26
-2
PFE
45
12
AME
75
3
NKE
31
-5
SLG
37
6
LB
33
2
AXP
74
4
Financhill
Back

First Trust Smith Opportunistic Fixed Income ETF Vs. Lyell Immunopharma, Inc. Industry Stock Comparison

Sell
28

FIXD
First Trust Smith Opportunistic Fixed Income ETF

Last Price:
$44.29
Seasonality Move:
0.28%
Buy
64

LYEL
Lyell Immunopharma, Inc.

Last Price:
$37.17
Seasonality Move:
-16.78%
Sell
28
First Trust Smith Opportunistic Fixed Income ETF (FIXD) is a Sell

Is First Trust Smith Opportunistic Fixed Income ETF a Buy, Sell or Hold?

  • The current First Trust Smith Opportunistic Fixed Income ETF [FIXD] share price is $44.28. The Score for FIXD is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • FIXD is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
64
Lyell Immunopharma, Inc. (LYEL) is a Buy

Is Lyell Immunopharma, Inc. a Buy, Sell or Hold?

  • The current Lyell Immunopharma, Inc. [LYEL] share price is $37.37. The Score for LYEL is 64, which is 28% above its historic median score of 50, and infers lower risk than normal.
  • LYEL is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

FIXD Stock Price Chart

What is First Trust Smith Opportunistic Fixed Income ETF's stock price today?

  • The First Trust Smith Opportunistic Fixed Income ETF share price today is $44.28
    Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and FIXD is experiencing buying pressure, which is a positive indicator for future bullish movement.

LYEL Stock Price Chart

What is Lyell Immunopharma, Inc.'s stock price today?

  • The Lyell Immunopharma, Inc. share price today is $37.37
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and LYEL is experiencing slight selling pressure.

FIXD Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.07 Sell
Relative Strength Index (14 RSI): 43.46 Sell
Chaikin Money Flow: 165541 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (44.29 - 44.57) Sell
Bollinger Bands (100): (44.09 - 44.71) Sell

LYEL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 4.08 Buy
Relative Strength Index (14 RSI): 79.16 Buy
Chaikin Money Flow: -97373 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): (20.11 - 32.35) Buy
Bollinger Bands (100): (10.77 - 23.75) Buy

FIXD Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 44.29 Sell
20-day SMA: 44.44 Sell
50-day SMA: 44.55 Sell
200-day SMA: 43.96 Buy
8-day EMA: 44.31 Sell
20-day EMA: 44.39 Sell
50-day EMA: 44.44 Sell
200-day EMA: 44.11 Buy

LYEL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 33.51 Buy
20-day SMA: 28.33 Buy
50-day SMA: 21.67 Buy
200-day SMA: 13.52 Buy
8-day EMA: 33.02 Buy
20-day EMA: 28.99 Buy
50-day EMA: 23.45 Buy
200-day EMA: 17.42 Buy

First Trust Smith Opportunistic Fixed Income ETF Earnings Growth & FIXD Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.00 per share, and a decrease next year of $0.00 per share.

Lyell Immunopharma, Inc. Earnings Growth & LYEL Earnings Dates

  • Analysts estimate an earnings increase this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, an increase this year of $9.86 per share, and a decrease next year of $3.96 per share.

First Trust Smith Opportunistic Fixed Income ETF Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Lyell Immunopharma, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):